GNS Partners with NCI on Personalized Treatment of NSCLC | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Healthcare IT firm GNS Healthcare is collaborating with the National Cancer Institute to help determine what treatments may work best for individuals with non-small cell lung cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.